Amoeba SA
PAR:ALMIB

Watchlist Manager
Amoeba SA Logo
Amoeba SA
PAR:ALMIB
Watchlist
Price: 0.77 EUR -1.28% Market Closed
Market Cap: 38.2m EUR
Have any thoughts about
Amoeba SA?
Write Note

Amoeba SA
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amoeba SA
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Amoeba SA
PAR:ALMIB
Income from Continuing Operations
-€14.3m
CAGR 3-Years
-21%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Robertet SA
PAR:RBT
Income from Continuing Operations
€87m
CAGR 3-Years
15%
CAGR 5-Years
10%
CAGR 10-Years
13%
Baikowski SA
PAR:ALBKK
Income from Continuing Operations
€669k
CAGR 3-Years
-49%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Sergeferrari Group SA
PAR:SEFER
Income from Continuing Operations
-€8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Orapi SA
PAR:ORAP
Income from Continuing Operations
-€31.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Groupe Berkem SA
PAR:ALKEM
Income from Continuing Operations
€367k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Amoeba SA
Glance View

Market Cap
38.2m EUR
Industry
Chemicals

Amoéba SA engages in developing, manufacturing and biological products. The company is headquartered in Chassieu, Auvergne-Rhone-Alpes and currently employs 22 full-time employees. The company went IPO on 2015-07-10. The firm specializes in disruptive biological solutions for the treatment of Legionella, amoeba and biofilm in water. The firm's offering includes products and services, such as: Cleantech biological solution, a patented technological disruptive product with no impact on the environment; amoebic analyses of waters of wet cooling towers (TAR), hot sanitary waters, industrial waters and waters of swimming pools; as well as Legionella tests of industrial waste water, among others. The firm is engaged in various technical, commercial, industrial and investment partnerships.

ALMIB Intrinsic Value
0.25 EUR
Overvaluation 67%
Intrinsic Value
Price

See Also

What is Amoeba SA's Income from Continuing Operations?
Income from Continuing Operations
-14.3m EUR

Based on the financial report for Dec 31, 2023, Amoeba SA's Income from Continuing Operations amounts to -14.3m EUR.

What is Amoeba SA's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-15%

Over the last year, the Income from Continuing Operations growth was -78%. The average annual Income from Continuing Operations growth rates for Amoeba SA have been -21% over the past three years , -15% over the past five years .

Back to Top